PT811386E - Metodo de seleccao de um sal para a preparacao de um complexo de inclusao - Google Patents

Metodo de seleccao de um sal para a preparacao de um complexo de inclusao

Info

Publication number
PT811386E
PT811386E PT97302821T PT97302821T PT811386E PT 811386 E PT811386 E PT 811386E PT 97302821 T PT97302821 T PT 97302821T PT 97302821 T PT97302821 T PT 97302821T PT 811386 E PT811386 E PT 811386E
Authority
PT
Portugal
Prior art keywords
salt
solubility
selecting
preparation
salts
Prior art date
Application number
PT97302821T
Other languages
English (en)
Inventor
Yesook Kim
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT811386E publication Critical patent/PT811386E/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
PT97302821T 1996-05-07 1997-04-24 Metodo de seleccao de um sal para a preparacao de um complexo de inclusao PT811386E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1686696P 1996-05-07 1996-05-07

Publications (1)

Publication Number Publication Date
PT811386E true PT811386E (pt) 2004-12-31

Family

ID=21779426

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97302821T PT811386E (pt) 1996-05-07 1997-04-24 Metodo de seleccao de um sal para a preparacao de um complexo de inclusao

Country Status (9)

Country Link
US (1) US20010007862A1 (pt)
EP (1) EP0811386B1 (pt)
JP (2) JP3007312B2 (pt)
AT (1) ATE277641T1 (pt)
CA (1) CA2204451C (pt)
DE (1) DE69730902T2 (pt)
DK (1) DK0811386T3 (pt)
ES (1) ES2224205T3 (pt)
PT (1) PT811386E (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA57734C2 (uk) 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
IL127497A (en) * 1997-12-18 2002-07-25 Pfizer Prod Inc Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders
JP4404547B2 (ja) * 2000-10-19 2010-01-27 バイオカルテイス・エス・エイ マイクロキャリアの識別用操作のための方法及び装置
US6884885B2 (en) 2000-12-21 2005-04-26 Cerestar Holding B.V. Production of cyclodextrin complexes
DE10215942A1 (de) * 2002-04-11 2003-10-23 Bayer Ag Wässrige Formulierungen von (2-Hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorbutan-1-sulfonat
PL375603A1 (en) * 2002-10-25 2005-12-12 Pfizer Products Inc. Depot formulations of arylheterocyclic active agents in the form of a suspension
US20050266398A1 (en) * 2004-06-01 2005-12-01 Peter Lea Method and device for rapid detection and quantitation of macro and micro matrices
WO2006010143A2 (en) * 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
CA2475191A1 (en) * 2004-07-20 2006-01-20 Biophys, Inc. System and method for rapid reading of macro and micro matrices
CA2475240A1 (en) * 2004-07-20 2006-01-20 Biophys, Inc. Method and device to measure dynamic internal calibration true dose response curves
CA2475456A1 (en) 2004-07-20 2006-01-20 Biophys, Inc. Method and device to optimize analyte and antibody substrate binding by least energy adsorption
CA2593497A1 (en) * 2005-02-11 2006-08-17 Judith Aronhime Amorphous ziprasidone mesylate
WO2006086787A1 (en) * 2005-02-11 2006-08-17 Teva Pharmaceutical Industries Ltd. Process of preparing ziprasidone mesylate
US20060270685A1 (en) * 2005-03-14 2006-11-30 Judith Aronhime Anhydrous ziprasidone mesylate and a process for its preparation
US20060270684A1 (en) * 2005-03-14 2006-11-30 Judith Aronhime Crystalline forms of ziprasidone mesylate
CA2569971A1 (en) * 2006-12-04 2008-06-04 Umedik Inc. Method for double-dip substrate spin optimization of coated micro array supports
WO2011080749A1 (en) * 2009-12-29 2011-07-07 Hetero Research Foundation Process for purification of ziprasidone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1269578B (it) * 1994-04-22 1997-04-08 Chiesi Farma Spa Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.
UA57734C2 (uk) * 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей

Also Published As

Publication number Publication date
ES2224205T3 (es) 2005-03-01
CA2204451C (en) 2004-06-29
JP2000086539A (ja) 2000-03-28
EP0811386A3 (en) 1999-02-10
JP3007312B2 (ja) 2000-02-07
JPH1059871A (ja) 1998-03-03
CA2204451A1 (en) 1997-11-07
DE69730902T2 (de) 2006-02-23
ATE277641T1 (de) 2004-10-15
EP0811386B1 (en) 2004-09-29
US20010007862A1 (en) 2001-07-12
MX9703304A (es) 1998-05-31
DK0811386T3 (da) 2005-01-03
DE69730902D1 (de) 2004-11-04
EP0811386A2 (en) 1997-12-10

Similar Documents

Publication Publication Date Title
PT811386E (pt) Metodo de seleccao de um sal para a preparacao de um complexo de inclusao
ATE128115T1 (de) 2-hydroxy-2-phenylethylaminderivate als beta-3- adrenoceptor agonisten.
IL133139A0 (en) Phthalamide derivatives or salts thereof as agrohorticultural insecticides and method for using the same
DE69928889D1 (de) System zur Verfolgung eines Objektes
DE3851951D1 (de) Amperometrische Messmethode Amperometrische Messmethode.
DE69841174D1 (de) Navigationssystem mit zentimetergenauigkeit, das niedrigfliegende satelliten verwendet
DE614536T1 (de) Laserdioden Entfernungsmessung.
DE59203135D1 (de) Windkanal mit freistrahlmessstrecke zur simulation von windrichtungsschwankungen.
ES2175349T3 (es) Composicion liquida acuosa para uso agricola.
DE59207944D1 (de) Korpuskularstrahltestverfahren mit Gegenspannungsnachführung
ATE230103T1 (de) Massstab einer längenmesseinrichtung sowie verfahren zur anbringung eines massstabs
DE59005960D1 (de) Vorrichtung zur absoluten zweidimensionalen positionsmessung.
FR2704068B1 (fr) Chapelet de sondes perfectionne.
NO932466D0 (no) Testsystem for feltmaaling
KR930007567U (ko) 길이조절을 할수있는 레이저 다이오드 미터 코팅용 지그
DE59202288D1 (de) Verfahren zur Gewinnung fester Farbstoffe.
FI935192A0 (fi) Substituerade benzotiazolderivat, deras framstaellning samt anvaendning som herbicider
DE68904045D1 (de) Referenzstrahlprojektionsapparat zur verwendung in vermessungseinrichtungen.
SE7909236L (sv) Adenosintrifosfatderivat
DE69205100T2 (de) Vorrichtung zur Schwachlichtmessung.
ES488175A0 (es) Procedimiento de obtencion de sales de aminas de n-fosfono- metilureas sustituidas.
DE69210619D1 (de) Temperaturmessung am ausgang eines verdampfers
SE9600623D0 (sv) Automation methodology for 3 D image metrology systems
DE69200210D1 (de) Klebrigkeitsprüfer.
DE59002669D1 (de) Strahlenteiler zur teilung eines optischen strahlengangs.